This site is intended for healthcare professionals
Atopic Dermatitis


Read time: 10 mins
Last updated:31th Mar 2020

Atopic dermatitis Guidelines

Consensus-based European guidelines


In 2018, a joint interdisciplinary European project updated the 2012 guidelines and developed extensive consensus-based guidelines and recommendations for the management of atopic dermatitis. A collaboration between several dermatology, immunology and allergy societies (consisting of the European Dermatology Forum (EDF), the European Academy of Dermatology and Venereology (EADV), the European Academy of Allergy and Clinical Immunology (EAACI), the European Task Force on Atopic Dermatitis (ETFAD), European Federation of Allergy and Airways Diseases Patients’ Associations (EFA), the European Society for Dermatology and Psychiatry (ESDaP), the European Society of Pediatric Dermatology (ESPD), Global Allergy and Asthma European Network (GA2LEN) and the European Union of Medical Specialists (UEMS)), it was decided that the guidelines should focus on therapeutic regimens rather than clinical entity, diagnosis or pathophysiology. Consensus was formed over a series of meetings between 2015 and 2017 and all recommendations required at least a 75% approval among the panel members (Wollenberg et al., 2018).

Register now for full access to

Developed by EPG Health for Medthority sponsored by Pfizer, with some scientific content provided by Pfizer.